News

May, 05

Stanford's Dr. Lau discussing the Typlit Platform

Dr. James Lau, Minimally invasive, laparoscopic and robotic surgeon at Stanford Hospital and Director of the Goodman Simulation Center discussing how Typlit aims to change the standard of care in cutting and ligation of tubular structures in the growing sector of Minimally invasive, Laparoscopic and Robotic surgery.

https://www.youtube.com/watch?v=OgtnPnfmWFA

Apr, 25

SPIRE Bioventures facilitates Spain and Portugal distribution agreement between DxNOW and CIMAB (Center of Male Infertility in Barcelona)

April 25th, 2017 -SPIRE Bioventures is delighted to announce that it has facilitated a distribution agreement between DxNow and CIMAB (Center of Male Infertility in Barcelona). CIMAB which is headquartered in Barcelona, Spain, will be distributing DxNow Fertile™ and Fertile Plus™ products in Spain and Portugal.

Mar, 31

Dr. Pablo Villoslada and Hassan Labay present at SPIRE Regulatory webinar for Canada CTA companies

March 31th, 2017 - SPIRE Bioventures would like to thank Dr. Pablo Villoslada (Neurologist, group leader at IDIBAPS-Hospital Clinic of Barcelona and former professor at UCSF) and Hassan Labay (Director of Regulatory Affairs at Abbott) for their great insight on FDA Regulatory strategy. The webinar was attended by the current cohort of...